{
  "ticker": "ZBIO",
  "company_name": "Zenas BioPharma, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05776121",
      "title": "Study of ZB001 in Chinese Patients With Thyroid Eye Disease",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Thyroid Eye Disease",
      "start_date": "2023-05-10",
      "completion_date": "2024-04-17",
      "enrollment": 0,
      "sponsor": "Zenas BioPharma (USA), LLC"
    },
    {
      "nct_id": "NCT07299019",
      "title": "A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis",
      "status": "NOT_YET_RECRUITING",
      "phase": "PHASE3",
      "condition": "Secondary Progressive Multiple Sclerosis",
      "start_date": "2026-03",
      "completion_date": "2030-07",
      "enrollment": 0,
      "sponsor": "Zenas BioPharma (USA), LLC"
    },
    {
      "nct_id": "NCT06559163",
      "title": "A Study of Obexelimab in Patients With Systemic Lupus Erythematosus",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Systemic Lupus Erythematosus",
      "start_date": "2024-09-17",
      "completion_date": "2026-09",
      "enrollment": 0,
      "sponsor": "Zenas BioPharma (USA), LLC"
    },
    {
      "nct_id": "NCT05542303",
      "title": "A Safety, Tolerability and Pharmacokinetics Study of ZB001 in Healthy Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteers",
      "start_date": "2022-10-16",
      "completion_date": "2023-04-04",
      "enrollment": 0,
      "sponsor": "Zenas BioPharma (USA), LLC"
    },
    {
      "nct_id": "NCT05662241",
      "title": "A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "IgG4 Related Disease",
      "start_date": "2022-09-30",
      "completion_date": "2029-02-15",
      "enrollment": 0,
      "sponsor": "Zenas BioPharma (USA), LLC"
    },
    {
      "nct_id": "NCT05794516",
      "title": "A Safety and Pharmacokinetics Study of ZB004 in Healthy Participants",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteers",
      "start_date": "2023-06-19",
      "completion_date": "2024-03-21",
      "enrollment": 0,
      "sponsor": "Zenas BioPharma (USA), LLC"
    },
    {
      "nct_id": "NCT05786573",
      "title": "A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Warm Autoimmune Hemolytic Anemia",
      "start_date": "2023-09-25",
      "completion_date": "2026-08-31",
      "enrollment": 0,
      "sponsor": "Zenas BioPharma (USA), LLC"
    },
    {
      "nct_id": "NCT06564311",
      "title": "A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Relapsing Multiple Sclerosis",
      "start_date": "2024-08-26",
      "completion_date": "2026-02",
      "enrollment": 0,
      "sponsor": "Zenas BioPharma (USA), LLC"
    },
    {
      "nct_id": "NCT05638854",
      "title": "A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid Arthritis",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Healthy Volunteers, Rheumatoid Arthritis",
      "start_date": "2022-12-08",
      "completion_date": "2025-07",
      "enrollment": 0,
      "sponsor": "Zenas BioPharma (USA), LLC"
    },
    {
      "nct_id": "NCT07067463",
      "title": "A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Multiple Sclerosis (MS) Primary Progressive",
      "start_date": "2025-12",
      "completion_date": "2030-07",
      "enrollment": 0,
      "sponsor": "Zenas BioPharma (USA), LLC"
    }
  ],
  "summary": {
    "total_trials": 10,
    "by_phase": {
      "PHASE1": 4,
      "PHASE3": 4,
      "PHASE2": 2
    },
    "by_status": {
      "COMPLETED": 3,
      "NOT_YET_RECRUITING": 1,
      "RECRUITING": 3,
      "ACTIVE_NOT_RECRUITING": 3
    },
    "active_trials": 6,
    "completed_trials": 3,
    "conditions": [
      "Healthy Volunteers",
      "Healthy Volunteers, Rheumatoid Arthritis",
      "IgG4 Related Disease",
      "Multiple Sclerosis (MS) Primary Progressive",
      "Relapsing Multiple Sclerosis",
      "Secondary Progressive Multiple Sclerosis",
      "Systemic Lupus Erythematosus",
      "Thyroid Eye Disease",
      "Warm Autoimmune Hemolytic Anemia"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:23:02.814320",
    "search_query": "Zenas BioPharma, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Zenas+BioPharma,+Inc."
  }
}